<DOC>
	<DOCNO>NCT00005769</DOCNO>
	<brief_summary>Considerable controversy exist regard effect estrogen progesterone insulin sensitivity postmenopausal woman . Thus , goal examine effect estradiol progestin vivo insulin sensitivity pathways intracellular glucose metabolism postmenopausal woman . This accomplished examining effect unopposed estrogen ( CEE ) combination estrogen progestin ( CEE/MPA ) versus placebo therapy 30 early menopausal woman ( defined 6 month 3 year post-cessation menses ) . Women treat 16 week outcome measure : 1 ) insulin sensitivity glucose oxidation determine euglycemic clamp , 2 ) assessment insulin sensitivity muscle biopsy culture primary endpoint glucose uptake glycogen accumulation/synthesis , 3 ) protein level insulin action cascade step base muscle biopsy Western blot .</brief_summary>
	<brief_title>Hormone Replacement Therapy Insulin Action : A Double-Blind , Parallel , Placebo-Controlled Hormone Intervention Study Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>6 month 3 year since cessation menses BMD 2433 surgically induce menopause</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2001</verification_date>
</DOC>